Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caligiuri

Showing results (911-920 of 1,066) with videos related to

Pageof 107
Sort By:
Blood|August 11, 2011
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemiaSebastian Schwind, Guido Marcucci, Jessica Kohlschmidt, et al.
European Heart Journal|September 19, 2014
Biomechanical factors in atherosclerosis: mechanisms and clinical implicationsBrenda R Kwak, Magnus Bäck, Marie-Luce Bochaton-Piallat, et al.
Chest|March 22, 2018
Cough Frequency During Treatment Associated With Baseline Cavitary Volume and Proximity to the Airway in Pulmonary TBAlvaro Proaño, David P Bui, José W López, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 2014
The natural product phyllanthusmin C enhances IFN-γ production by human NK cells through upregulation of TLR-mediated NF-κB signalingYoucai Deng, Jianhong Chu, Yulin Ren, et al.
The Journal of Clinical Investigation|July 24, 2012
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liverShu-Hao Hsu, Bo Wang, Janaiah Kota, et al.
Blood|April 13, 2013
MicroRNAs activate natural killer cells through Toll-like receptor signalingShun He, Jianhong Chu, Lai-Chu Wu, et al.
Cancer|January 3, 2014
Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808Jonathan E Kolitz, Stephen L George, Don M Benson, et al.
Scientific Reports|July 10, 2015
CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem CellsJianfeng Han, Jianhong Chu, Wing Keung Chan, et al.
European Heart Journal|June 7, 2015
Novel methodologies for biomarker discovery in atherosclerosisImo E Hoefer, Sabine Steffens, Mika Ala-Korpela, et al.
Cancer Research|March 15, 1996
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11M A Caligiuri, M P Strout, S A Schichman, et al.
Pageof 107

Showing results (911-920 of 1,066) with videos related to

Sort By:
Pageof 107
Blood|August 11, 2011
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemiaSebastian Schwind, Guido Marcucci, Jessica Kohlschmidt, et al.
European Heart Journal|September 19, 2014
Biomechanical factors in atherosclerosis: mechanisms and clinical implicationsBrenda R Kwak, Magnus Bäck, Marie-Luce Bochaton-Piallat, et al.
Chest|March 22, 2018
Cough Frequency During Treatment Associated With Baseline Cavitary Volume and Proximity to the Airway in Pulmonary TBAlvaro Proaño, David P Bui, José W López, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 2014
The natural product phyllanthusmin C enhances IFN-γ production by human NK cells through upregulation of TLR-mediated NF-κB signalingYoucai Deng, Jianhong Chu, Yulin Ren, et al.
The Journal of Clinical Investigation|July 24, 2012
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liverShu-Hao Hsu, Bo Wang, Janaiah Kota, et al.
Blood|April 13, 2013
MicroRNAs activate natural killer cells through Toll-like receptor signalingShun He, Jianhong Chu, Lai-Chu Wu, et al.
Cancer|January 3, 2014
Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808Jonathan E Kolitz, Stephen L George, Don M Benson, et al.
Scientific Reports|July 10, 2015
CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem CellsJianfeng Han, Jianhong Chu, Wing Keung Chan, et al.
European Heart Journal|June 7, 2015
Novel methodologies for biomarker discovery in atherosclerosisImo E Hoefer, Sabine Steffens, Mika Ala-Korpela, et al.
Cancer Research|March 15, 1996
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11M A Caligiuri, M P Strout, S A Schichman, et al.
Pageof 107